|
Volumn 19, Issue 3, 2001, Pages 145-149
|
Results of combined-modality therapy for primary and secondary malignant lymphoma of the Central Nervous System (CNS)
a a a a a |
Author keywords
Combined modality therapy; Comparison with primary CNS lymphoma; Local control of secondary CNS lymphoma
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DEXAMETHASONE;
DOXORUBICIN;
ETOPOSIDE;
FLUOROURACIL;
IFOSFAMIDE;
METHOTREXATE;
PREDNISOLONE;
VINCRISTINE;
ADULT;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SURGERY;
CENTRAL NERVOUS SYSTEM METASTASIS;
CENTRAL NERVOUS SYSTEM TUMOR;
CLINICAL ARTICLE;
HISTOPATHOLOGY;
HUMAN;
LYMPHOMA;
MULTIMODALITY CANCER THERAPY;
PROGNOSIS;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADULT;
AGED;
CENTRAL NERVOUS SYSTEM NEOPLASMS;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
LYMPHOMA, DIFFUSE;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 0034944149
PISSN: 02882043
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (19)
|